Pio Pharmaceutical to Participate in Renmark Virtual Roadshow

PHIO Phio Pharmaceuticals Corp

$0.99 -1.49%

View chart & analysis →

1. 1Pio Pharmaceuticals (PHIO) announced its participation in Renmark Financial's virtual non-deal roadshow series.
2. 2CEO and Chairman Robert Bitterman will introduce the INTASYL siRNA platform and lead candidate PH-762 and hold a live Q&A session on Thursday, July 28 at 12:00 p.m. Eastern Time.
3. 3PH-762 is a non-surgical therapeutic candidate for the treatment of skin cancer, and a replay of the event will be available on the Renmark Financial website.

Source Newsfile Corp. +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →